Farther Finance Advisors, LLC Virax Biolabs Group LTD Transaction History

Farther Finance Advisors, LLC

  • $6.63 Trillion
  • Q3 2025

A detailed history of Farther Finance Advisors, LLC transactions in Virax Biolabs Group LTD stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 21 shares of VRAX stock, worth $10. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Holding current value
$10
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025
BUY
$0.56 - $1.11 $11 - $23
21 New
21 $13,000

Others Institutions Holding VRAX

# of Institutions
1
Shares Held
21
Call Options Held
0
Put Options Held
0
View Full List

About Virax Biolabs Group Ltd

VRAX Quotes by TradingView
  • Ticker VRAX
  • Exchange
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,374,100
  • Market Cap $5.57M
  • Description
  • Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid te...
More about VRAX
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email